1. Combining an amyloid‐beta (Aβ) cleaving enzyme inhibitor with a γ‐secretase modulator results in an additive reduction of Aβ production. (7th November 2014) Authors: Strömberg, Kia; Eketjäll, Susanna; Georgievska, Biljana; Tunblad, Karin; Eliason, Kristina; Olsson, Fredrik; Radesäter, Ann‐Cathrin; Klintenberg, Rebecka; Arvidsson, Per I.; von Berg, Stefan; Fälting, Johanna; Cowburn, Richard F.; Dabrowski, Michael Journal: FEBS journal Issue: Volume 282:Number 1(2015) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Imatinib treatment and Aβ42 in humans. (12th December 2013) Authors: Olsson, Bob; Legros, Laurence; Guilhot, François; Strömberg, Kia; Smith, James; Livesey, Frederick J.; Wilson, David H.; Zetterberg, Henrik; Blennow, Kaj Journal: Alzheimer's & dementia Issue: Volume 10(2014)Supplement 5 Page Start: S374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tau‐Tubulin Kinase 1 Expression, Phosphorylation and Co‐Localization with Phospho‐Ser422 Tau in the Alzheimer's Disease Brain. (20th November 2012) Authors: Lund, Harald; Cowburn, Richard F.; Gustafsson, Elin; Strömberg, Kia; Svensson, Anne; Dahllund, Leif; Malinowsky, David; Sunnemark, Dan Journal: Brain pathology Issue: Volume 23:Number 4(2013:Jul.) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗